NYSE:GRDN Guardian Pharmacy Services (GRDN) Stock Price, News & Analysis $36.30 +0.48 (+1.33%) Closing price 03:59 PM EasternExtended Trading$36.54 +0.24 (+0.67%) As of 04:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Guardian Pharmacy Services Stock (NYSE:GRDN) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get GRDN alerts:Sign Up Key Stats Today's Range$35.12▼$36.9750-Day Range$32.29▼$40.6052-Week Range$19.17▼$41.36Volume403,978 shsAverage Volume389,321 shsMarket Capitalization$1.81 billionP/E Ratio43.73Dividend YieldN/APrice Target$41.33Consensus RatingModerate Buy Company Overview Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia. Read More Guardian Pharmacy Services Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks48th Percentile Overall ScoreGRDN MarketRank™: Guardian Pharmacy Services scored higher than 48% of companies evaluated by MarketBeat, and ranked 411th out of 851 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingModerate Buy Consensus RatingGuardian Pharmacy Services has received a consensus rating of Moderate Buy. The company's average rating score is 2.78, and is based on no strong buy ratings, 7 buy ratings, 2 hold ratings, and no sell ratings.Upside PotentialGuardian Pharmacy Services has a consensus price target of $41.33, representing about 13.9% upside from its current price of $36.30.Amount of Analyst CoverageGuardian Pharmacy Services has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Guardian Pharmacy Services' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth10.26% Earnings GrowthEarnings for Guardian Pharmacy Services are expected to grow by 10.26% in the coming year, from $1.17 to $1.29 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Guardian Pharmacy Services is 43.73, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.65.Price to Earnings Ratio vs. SectorThe P/E ratio of Guardian Pharmacy Services is 43.73, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 20.58.Price to Earnings Growth RatioGuardian Pharmacy Services has a PEG Ratio of 2.43. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioGuardian Pharmacy Services has a P/B Ratio of 10.55. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted8.08% of the float of Guardian Pharmacy Services has been sold short.Short Interest Ratio / Days to CoverGuardian Pharmacy Services has a short interest ratio ("days to cover") of 8.23.Change versus previous monthShort interest in Guardian Pharmacy Services has recently increased by 6.95%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldGuardian Pharmacy Services does not currently pay a dividend.Dividend GrowthGuardian Pharmacy Services does not have a long track record of dividend growth. News and Social Media2.0 / 5News Sentiment0.27 News SentimentGuardian Pharmacy Services has a news sentiment score of 0.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.39 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Guardian Pharmacy Services this week, compared to 2 articles on an average week.Search InterestOnly 2 people have searched for GRDN on MarketBeat in the last 30 days. This is a decrease of -82% compared to the previous 30 days. Company Ownership1.4 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Guardian Pharmacy Services insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $288,679,700.00 in company stock.Percentage Held by Insiders32.96% of the stock of Guardian Pharmacy Services is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsGuardian Pharmacy Services has minimal institutional ownership at this time.Read more about Guardian Pharmacy Services' insider trading history. Receive GRDN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Guardian Pharmacy Services and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GRDN Stock News HeadlinesStatutory Profit Doesn't Reflect How Good Guardian Pharmacy Services' (NYSE:GRDN) Earnings AreMay 14, 2026 | finance.yahoo.comGuardian Pharmacy Services, Inc. (GRDN) Presents at Bank of America Global Healthcare Conference 2026 TranscriptMay 13, 2026 | seekingalpha.comNobody Understands Why Trump Is Invading Iran (here’s the answer)Most investors are reacting to the Iran strikes without understanding the underlying motive driving the decision. Addison Wiggin, Founder of Grey Swan Investment Fraternity, says there is a hidden reason behind the bombing - and knowing it could change how you position your money right now.May 19 at 1:00 AM | Banyan Hill Publishing (Ad)Guardian Pharmacy Services Signals Strength Amid IRA ShockMay 10, 2026 | tipranks.comThe Bull Case For Guardian Pharmacy Services (GRDN) Could Change Following Strong Q1 Beat And New Shelf RegistrationMay 10, 2026 | finance.yahoo.comGuardian Pharmacy Services, Inc. Class A (GRDN) Receives a Buy from Bank of America SecuritiesMay 8, 2026 | theglobeandmail.comGuardian Pharmacy Services, Inc. (NYSE:GRDN) Q1 2026 Earnings Call TranscriptMay 8, 2026 | insidermonkey.comGuardian Pharmacy Stockholders Back Directors, Pay and AuditorMay 7, 2026 | tipranks.comSee More Headlines GRDN Stock Analysis - Frequently Asked Questions How have GRDN shares performed this year? Guardian Pharmacy Services' stock was trading at $30.01 at the beginning of the year. Since then, GRDN stock has increased by 20.9% and is now trading at $36.2970. How were Guardian Pharmacy Services' earnings last quarter? Guardian Pharmacy Services, Inc. (NYSE:GRDN) posted its quarterly earnings results on Wednesday, May, 6th. The company reported $0.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.24 by $0.05. The company's quarterly revenue was up 2.2% on a year-over-year basis. Read the conference call transcript. When did Guardian Pharmacy Services IPO? Guardian Pharmacy Services (GRDN) raised $102 million in an initial public offering (IPO) on Thursday, September 26th 2024. The company issued 6,800,000 shares at $14.00-$16.00 per share. Raymond James, Stifel and Truist Securities acted as the underwriters for the IPO. Who are Guardian Pharmacy Services' major shareholders? Top institutional shareholders of Guardian Pharmacy Services include Jennison Associates LLC (1.30%), Sei Investments Co. (0.72%), Dimensional Fund Advisors LP (0.33%) and Peregrine Capital Management LLC (0.32%). Insiders that own company stock include William E Bindley, Thomas J Salentine Jr, Fred Burke, Kendall Forbes, John Ackerman, Equity Fund LP Cardinal, David K Morris and Steven D Cosler. View institutional ownership trends. How do I buy shares of Guardian Pharmacy Services? Shares of GRDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Guardian Pharmacy Services own? Based on aggregate information from My MarketBeat watchlists, some other companies that Guardian Pharmacy Services investors own include UnitedHealth Group (UNH) and Meta Platforms (META). Company Calendar Last Earnings5/06/2026Today5/19/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (7m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 GRDN's financial health is in the Green zone, according to TradeSmith. GRDN has been in this zone for over 7 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MED - DRUGS Sub-IndustryRetail Current SymbolNYSE:GRDN Previous SymbolNYSE:GRDN CIK1802255 Webguardianpharmacy.com Phone(404) 810-0089FaxN/AEmployees3,600Year Founded2004Price Target and Rating Average Price Target for Guardian Pharmacy Services$41.33 High Price Target$44.00 Low Price Target$36.00 Potential Upside/Downside+13.9%Consensus RatingModerate Buy Rating Score (0-4)2.78 Research Coverage9 Analysts Profitability EPS (Trailing Twelve Months)$0.83 Trailing P/E Ratio43.73 Forward P/E Ratio30.76 P/E Growth2.35Net Income$49.22 million Net Margins3.64% Pretax Margin5.40% Return on Equity30.72% Return on Assets15.99% Debt Debt-to-Equity RatioN/A Current Ratio1.46 Quick Ratio1.17 Sales & Book Value Annual Sales$1.45 billion Price / Sales1.25 Cash Flow$1.28 per share Price / Cash Flow28.44 Book Value$4.67 per share Price / Book7.77Miscellaneous Outstanding Shares49,780,000Free Float33,373,000Market Cap$1.81 billion OptionableN/A Beta0.09 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NYSE:GRDN) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardian Pharmacy Services, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guardian Pharmacy Services With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
